Payment overview · 2025
General Payments
$90.48
5 reported records · 4 companies
Healthcare provider profile · identity verified
Howard Seth Levine, D.O.
Allopathic & Osteopathic Physicians|Family Medicine · BAYONNE, NJ · NPI 1578562948
Verified facts
What the public records show
CMS Open Payments records show Howard Seth Levine, D.O. received $90.48 in general payments during 2025 across 5 reported records.
Amgen Inc. accounted for 40.9% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Eliquis.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 26 claims for Ozempic by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 609 claims for Eliquis by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Amgen Inc. | Unresolved — no canonical attribution shown | $36.96 | 40.9% | 2 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $19.05 | 21.1% | 1 | 2025 |
| Merck Sharp & Dohme LLC | Unresolved — no canonical attribution shown | $18.12 | 20.0% | 1 | 2025 |
| PFIZER INC. | Unresolved — no canonical attribution shown | $16.35 | 18.1% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $90.48 | 5 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| KRYSTEXXA Normalized: krystexxa |
Biological | Amgen Inc. | $36.96 | 2 | 2025 |
Source payment records
|
|||||
| CAPVAXIVE Normalized: capvaxive |
Biological | Merck Sharp & Dohme LLC | $18.12 | 1 | 2025 |
Source payment records
|
|||||
| GARDASIL 9 Normalized: gardasil 9 |
Biological | Merck Sharp & Dohme LLC | $18.12 | 1 | 2025 |
Source payment records
|
|||||
| ELIQUIS Normalized: eliquis |
Drug | PFIZER INC. | $16.35 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| ELIQUIS eliquis |
2025 | Eliquis | 2024 | 609 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
26 | suppressed by CMS |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
609 | 89 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1020 | 258 |
| Amlodipine Besylate | Amlodipine Besylate | 818 | 200 |
| Eliquis | Apixaban | 609 | 89 |
| Losartan Potassium | Losartan Potassium | 555 | 144 |
| Levothyroxine Sodium | Levothyroxine Sodium | 546 | 114 |
| Pantoprazole Sodium | Pantoprazole Sodium | 528 | 137 |
| Metoprolol Tartrate | Metoprolol Tartrate | 420 | 95 |
| Furosemide | Furosemide | 397 | 122 |
| Metformin Hcl | Metformin Hcl | 382 | 99 |
| Alprazolam | Alprazolam | 359 | 73 |
| Fenofibrate | Fenofibrate Nanocrystallized | 301 | 64 |
| Tamsulosin Hcl | Tamsulosin Hcl | 289 | 64 |
| Clopidogrel | Clopidogrel Bisulfate | 281 | 74 |
| Metoprolol Succinate | Metoprolol Succinate | 246 | 65 |
| Januvia | Sitagliptin Phosphate | 236 | 42 |
| Lisinopril | Lisinopril | 227 | 62 |
| Zolpidem Tartrate | Zolpidem Tartrate | 226 | 40 |
| Gabapentin | Gabapentin | 205 | 62 |
| Hydrochlorothiazide | Hydrochlorothiazide | 203 | 69 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 177 | 50 |
| Famotidine | Famotidine | 172 | 53 |
| Azithromycin | Azithromycin | 169 | 121 |
| Carvedilol | Carvedilol | 169 | 40 |
| Simvastatin | Simvastatin | 161 | 30 |
| Sertraline Hcl | Sertraline Hcl | 160 | 36 |
| Potassium Chloride | Potassium Chloride | 156 | 37 |
| Clonidine Hcl | Clonidine Hcl | 147 | 29 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 141 | 45 |
| Omeprazole | Omeprazole | 134 | 41 |
| Warfarin Sodium | Warfarin Sodium | 130 | suppressed |
| Levetiracetam | Levetiracetam | 124 | 22 |
| Donepezil Hcl | Donepezil Hcl | 114 | 20 |
| Divalproex Sodium | Divalproex Sodium | 111 | 18 |
| Mupirocin | Mupirocin | 106 | 56 |
| Spironolactone | Spironolactone | 106 | 26 |
| Quetiapine Fumarate | Quetiapine Fumarate | 98 | 18 |
| Allopurinol | Allopurinol | 97 | 18 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 90 | 45 |
| Cephalexin | Cephalexin | 89 | 71 |
| Finasteride | Finasteride | 83 | 19 |
| Ibuprofen | Ibuprofen | 83 | 32 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 80 | 18 |
| Fluticasone Propionate | Fluticasone Propionate | 77 | 37 |
| Clonazepam | Clonazepam | 76 | 18 |
| Mirtazapine | Mirtazapine | 76 | 13 |
| Hydralazine Hcl | Hydralazine Hcl | 75 | 25 |
| Ondansetron Hcl | Ondansetron Hcl | 74 | 34 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 70 | 56 |
| Lidocaine | Lidocaine | 70 | 19 |
| Memantine Hcl | Memantine Hcl | 70 | 13 |
| Entresto | Sacubitril/Valsartan | 67 | suppressed |
| Trazodone Hcl | Trazodone Hcl | 66 | 14 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 65 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 64 | 14 |
| Lorazepam | Lorazepam | 64 | 15 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 63 | 28 |
| Enoxaparin Sodium | Enoxaparin Sodium | 63 | 12 |
| Paroxetine Hcl | Paroxetine Hcl | 63 | 12 |
| Risperidone | Risperidone | 62 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 60 | 14 |
| Celecoxib | Celecoxib | 60 | 28 |
| Latanoprost | Latanoprost | 60 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 57 | 27 |
| Digoxin | Digoxin | 56 | 12 |
| Meloxicam | Meloxicam | 56 | 13 |
| Humulin R | Insulin Regular, Human | 55 | 12 |
| Valsartan | Valsartan | 55 | 16 |
| Ezetimibe | Ezetimibe | 54 | 14 |
| Montelukast Sodium | Montelukast Sodium | 51 | 16 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 50 | 35 |
| Colchicine | Colchicine | 49 | 12 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 48 | 13 |
| Levofloxacin | Levofloxacin | 47 | 28 |
| Pravastatin Sodium | Pravastatin Sodium | 47 | 16 |
| Glipizide | Glipizide | 45 | 15 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 45 | 15 |
| Nystatin | Nystatin | 43 | 20 |
| Enalapril Maleate | Enalapril Maleate | 42 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 41 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 41 | 12 |
| Santyl | Collagenase Clostridium Hist. | 41 | suppressed |
| Linzess | Linaclotide | 40 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 38 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 38 | suppressed |
| Pregabalin | Pregabalin | 38 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 37 | suppressed |
| Atenolol | Atenolol | 37 | 12 |
| Doxycycline Hyclate | Doxycycline Hyclate | 37 | 31 |
| Glimepiride | Glimepiride | 37 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 37 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 36 | 15 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 36 | 16 |
| Prednisone | Prednisone | 35 | 26 |
| Primidone | Primidone | 35 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 33 | suppressed |
| Topiramate | Topiramate | 33 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 32 | suppressed |
| Naproxen | Naproxen | 31 | 17 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 31 | 28 |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 30 | 15 |
| Sevelamer Carbonate | Sevelamer Carbonate | 30 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 29 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 29 | suppressed |
| Lovastatin | Lovastatin | 29 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 29 | suppressed |
| Sucralfate | Sucralfate | 29 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 28 | suppressed |
| Ondansetron Odt | Ondansetron | 28 | suppressed |
| Sps | Sodium Polystyrene Sulfon/Sorb | 28 | suppressed |
| Trulicity | Dulaglutide | 28 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 27 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 27 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 27 | 11 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 26 | suppressed |
| Ozempic | Semaglutide | 26 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 26 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 26 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 25 | suppressed |
| Tobramycin-Dexamethasone | Tobramycin/Dexamethasone | 25 | 12 |
| Jardiance | Empagliflozin | 24 | suppressed |
| Olanzapine | Olanzapine | 24 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 23 | suppressed |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 22 | suppressed |
| Bupropion Xl | Bupropion Hcl | 22 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 21 | 11 |
| Methylprednisolone | Methylprednisolone | 21 | 13 |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 21 | 18 |
| Repaglinide | Repaglinide | 21 | suppressed |
| Torsemide | Torsemide | 21 | suppressed |
| Aripiprazole | Aripiprazole | 20 | suppressed |
| Calcitriol | Calcitriol | 20 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 20 | suppressed |
| Fentanyl | Fentanyl | 20 | suppressed |
| Gemfibrozil | Gemfibrozil | 20 | suppressed |
| Insulin Lispro | Insulin Lispro | 20 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 20 | suppressed |
| Ranolazine Er | Ranolazine | 20 | suppressed |
| Xarelto | Rivaroxaban | 20 | suppressed |
| Glyburide | Glyburide | 19 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 19 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 19 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 18 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 18 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 18 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 18 | suppressed |
| Ramipril | Ramipril | 18 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 18 | suppressed |
| Amoxicillin | Amoxicillin | 17 | 14 |
| Fenofibrate | Fenofibrate | 17 | suppressed |
| Glipizide Er | Glipizide | 17 | suppressed |
| Nabumetone | Nabumetone | 17 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 17 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 17 | suppressed |
| Tradjenta | Linagliptin | 17 | suppressed |
| Ursodiol | Ursodiol | 17 | suppressed |
| Baclofen | Baclofen | 16 | suppressed |
| Vascepa | Icosapent Ethyl | 16 | suppressed |
| Alphagan P | Brimonidine Tartrate | 15 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 15 | suppressed |
| Bumetanide | Bumetanide | 15 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 15 | suppressed |
| Lactulose | Lactulose | 15 | suppressed |
| Levemir | Insulin Detemir | 15 | suppressed |
| Carbamazepine | Carbamazepine | 14 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 14 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 14 | suppressed |
| Temazepam | Temazepam | 14 | suppressed |
| Tobramycin | Tobramycin | 14 | suppressed |
| Bicalutamide | Bicalutamide | 13 | suppressed |
| Clonidine | Clonidine | 13 | suppressed |
| Methotrexate | Methotrexate Sodium | 13 | suppressed |
| Novolin R | Insulin Regular, Human | 13 | suppressed |
| Prasugrel Hcl | Prasugrel Hcl | 13 | suppressed |
| Telmisartan | Telmisartan | 13 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 13 | suppressed |
| Desmopressin Acetate | Desmopressin (Nonrefrigerated) | 12 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 12 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 12 | suppressed |
| Metronidazole | Metronidazole | 12 | suppressed |
| Myrbetriq | Mirabegron | 12 | suppressed |
| Pradaxa | Dabigatran Etexilate Mesylate | 12 | suppressed |
| Sodium Chloride | Sodium Chloride 0.45 % | 12 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 11 | suppressed |
| Carbamazepine Er | Carbamazepine | 11 | suppressed |
| Clotrimazole | Clotrimazole | 11 | suppressed |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 11 | suppressed |
| Dutasteride | Dutasteride | 11 | suppressed |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 11 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $90.48 · 5 records | Amgen Inc. | CAPVAXIVE, ELIQUIS, GARDASIL 9, KRYSTEXXA | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Eliquis play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error